Acorda Therapeutics, Inc. Long-term Debt, Gross
Acorda Therapeutics, Inc. had Long-term Debt, Gross of $207.00 million as of 2021-12-31, per its 10-K filed 2022-03-18.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2022-03-18
- 2021-12-31: Long-term Debt, Gross $207.00M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2021-12-31 | $207.00M 10-K · filed 2022-03-18 |